Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
250.00    0.00 (0.00%)
Bid:
245.00
Ask:
255.00
Spread: 10.00 (4.082%)
Market Cap: £227.11m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Board Changes

12 May 2021 09:00

RNS Number : 2860Y
Concurrent Technologies PLC
12 May 2021
 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain

 

12 May 2021

 

Concurrent Technologies Plc

 

Board Changes

 

Concurrent Technologies Plc (AIM: CNC), a world leading specialist in the design and manufacture of high-performance embedded computer boards for critical applications, is pleased to announce the appointment of Dr Miles Adcock as Chief Executive Officer and as an executive director of the Company with effect from 21 June 2021.

 

The Company also announces today that Jane Annear, Managing Director, has given notice of her retirement after 36 years of outstanding service to the Company. Jane will work to support Miles in her remaining time with the Company in order to ensure an orderly transition and will continue as an executive director of the Company during that time.

 

Dr Miles Adcock is currently President of Space Imaging at Teledyne Technologies Inc. Prior to joining Teledyne, Miles held senior roles at QinetiQ Group plc including as Managing Director of its Cyber, Information & Training business unit and as Group Engineering Director. He has previously worked at BAE Systems and GEC Marconi. A Chartered Engineer and a Chartered Physicist, he received his PhD in Adaptive Optics from Imperial College, London.

 

Mark Cubitt, Non-executive Chairman of Concurrent Technologies, commented:

 

"We are delighted to welcome Miles as Chief Executive Officer of Concurrent Technologies. His experience in growing international based technology companies will help drive forward the Company to take the next steps in our development as a leading player in the high performance embedded market. It is also important we recognise today the significant role Jane has played in the growth of the Company, which she has served since she joined as our second employee on incorporation in 1985."

 

Dr Miles Adcock commented:

 

"I am very pleased to take up this role. Concurrent Technologies is a fantastic organisation. We have great people and technological capabilities and a competitive customer offering. I look forward to leading Concurrent Technologies in its next phase of growth and creating value for all our stakeholders."

 

Jane Annear, Managing Director, commented:

 "It has been a privilege to lead the team at Concurrent Technologies for the last 2 years and I would like to thank all of our employees for their commitment and support during that time. I am pleased to welcome Miles to the role of Chief Executive Officer in a new and exciting era for the Company."

 

 

 

 

Enquiries:

 

Concurrent Technologies PlcJane Annear, Managing Director

 

+44 (0)1206 752626

Newgate (Financial PR)Bob Huxford

Isabelle Smurfit

 

+44 (0)20 7653 9848+44 (0)20 3757 3411

Cenkos Securities Plc (NOMAD)Neil McDonald

Peter Lynch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

The following information regarding the appointment of Dr Miles Adcock (aged 48) is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies:

 

Full Name:

Miles John Adcock

 

Current Directorship / Partnerships:

South East LEP Limited

Teledyne e2v Ltd

Teledyne UK Limited

 

Previous Directorship / Partnerships:

BJ Trustee Limited

Bolden James Limited

Cuesim Limited

Gyldan 11 Limited

Leading Technology Limited

Qinetiq Special Project Inc.

 

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest 9th generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom® processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

 

For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.

 

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKSFFFLFEFA
Date   Source Headline
14th May 20267:00 amRNSPosting of Annual Report and Notice of AGM
13th Apr 20267:01 amRNSBoard change
13th Apr 20267:00 amRNSFinal results for the year ended 31 December 2025
31st Mar 20265:24 pmRNSBlock Admission Application
30th Mar 20267:00 amRNSNotice of Results and Investor Presentation
10th Mar 20267:00 amRNSLaunch of Next-Generation Computing Products
25th Feb 20267:00 amRNSHolding(s) in Company
16th Feb 20267:00 amRNSAppointment of Nominated Adviser and Broker
27th Jan 20267:00 amRNSNew Managing Director of Products Appointed
26th Jan 20267:00 amRNSNew Product Announcement
20th Jan 20267:00 amRNSTrading Update
23rd Dec 20257:00 amRNSUpdate on Expanded HQ and Manufacturing Facility
23rd Dec 20257:00 amRNSUpdate on Expanded HQ and Manufacturing Facility
12th Dec 20254:43 pmRNSExercise of Options and TVR
9th Dec 202512:46 pmRNSExercise of Options, Director Dealing and TVR
5th Dec 202512:15 pmRNSExercise of Share Options and Total Voting Rights
27th Nov 20254:46 pmRNSExercise of Options, Director Dealing and TVR
1st Oct 20257:00 amRNSIssue of Share Options and PDMR Dealing
19th Sep 20255:36 pmRNSDirector Share Dealing
19th Sep 20257:00 amRNS$5.25m US Defence Contract Secured
8th Sep 20257:00 amRNSInterim Results
4th Sep 20257:00 amRNSRecord UK defence contract secured for £4m
20th Aug 20257:00 amRNSNew Product Launch
13th Aug 20254:20 pmRNSInvestor Meet Company Presentation Update
12th Aug 20257:00 amRNSLaunch of Compact Computer System
29th Jul 20257:00 amRNSNotice of Results and Investor Presentation
16th Jul 20255:25 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSH1 FY25 Trading Update
8th Jul 20252:13 pmRNSExercise of Options, New Ordinary Shares and TVR
1st Jul 20255:51 pmRNSHolding(s) in Company
25th Jun 20257:00 amRNSHolding(s) in Company
18th Jun 20252:19 pmRNSExercise of Options, New Ordinary Shares and TVR
13th Jun 20257:00 amRNSResults of Annual General Meeting
23rd May 20251:07 pmRNSExercise of Options, New Ordinary Shares and TVR
16th May 202510:53 amRNSPosting of Annual Report and Notice of AGM
15th May 20251:28 pmRNSHolding(s) in Company
8th May 20257:00 amRNSExercise of Options, New Ordinary Shares and TVR
28th Apr 20257:00 amRNSExercise of Options
24th Apr 20251:25 pmRNSExercise of Options, Director Dealing and TVR
23rd Apr 20254:01 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSFinal Results for the year ended 31 December 2024
7th Apr 20257:00 amRNSNotice of Results and Investor Presentation
31st Mar 20257:00 amRNSLease agreed for new HQ & manufacturing facility
17th Mar 202510:46 amRNSHolding(s) in Company
3rd Mar 20257:00 amRNSNew Product Announcement
28th Feb 20257:00 amRNSDirector Share Dealing
13th Feb 20257:00 amRNSCommencement of Trading on OTCQX in the U.S.
27th Jan 20257:00 amRNSMajor VME Product Order from Long-Term Customer
17th Jan 20259:22 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.